Search for Clinical Trial Results

Membranous Nephropathy - 27 Studies Found
Status | Study |
Active, not recruiting |
Study Name: MEmbranous Nephropathy Trial Of Rituximab Condition: Idiopathic Membranous Nephropathy Date: 2010-08-10 Interventions:
|
Withdrawn |
Study Name: Aliskiren in Patients With Idiopathic Membranous Nephropathy Condition: Idiopathic Membranous Nephropathy Date: 2010-03-24 Interventions: Drug: Aliskiren Aliskiren dose will begin with 150mg per day and later up-titrated to the maximum availa |
Not yet recruiting |
Study Name: Adrenocorticotropic Hormone in Membranous Nephropathy Condition: Membranous Nephropathy Date: 2017-01-17 Interventions: Drug: ACTHar for 6 months Other Names: |
Recruiting |
Study Name: Sequential Therapy With Tacrolimus and Rituximab in Primary Membranous Nephropathy Condition: MEMBRANOUS NEPHROPATHY Date: 2013-09-19 Interventions:
|
Active, not recruiting |
Study Name: Evaluate Rituximab Treatment for Idiopathic Membranous Nephropathy Condition: Idiopathic Membranous Nephropathy Date: 2011-12-09 Interventions:
|
Completed |
Study Name: Rituximab in Membranous Nephropathy Condition: Membranous Nephropathy Date: 2007-01-19 Interventions: Drug: Rituximab |
Active, not recruiting |
Study Name: Clinical Study of QingReMoShen Granule to Treat Idiopathic Membranous Nephropathy Condition: Idiopathic Membranous Nephropathy Date: 2013-04-29 Interventions:
|
Completed |
Study Name: Rituximab in the Treatment of Idiopathic Membranous Nephropathy Condition: Membranous Nephropathy Date: 2006-11-29 Interventions: Drug: Rituximab Patients will received rituximab 4 weekly doses of rituximab 375 mg/m2 at baseline. Pati |
Recruiting |
Study Name: Role of Anti-mouse PLA2R1 ELISA in Membranous Nephropathy Condition: Membranous Nephropathy Date: 2014-07-22 Interventions: Procedure: Blood and urine analysis creatinine, albumin, blood electrolytes, proteinuria / creatinine in |
Completed |
Study Name: Treatment With Synthetic ACTH in High Risk Patients With Membranous Nephropathy Condition: Idiopathic Membranous Nephropathy Date: 2008-06-09 Interventions: Drug: tetracosactide hexacetaat Intramuscular injections with tetracosactide hexacetaat (Synacthen Depot |